Medical Research News

Nursing

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kwok J S-S et al. - Spironolactone is not effective in the treatment of hypokalemia in stable CAPD patients, but the agent is well tolerated, at least in CAPD patients with little residual renal function. Future studies are warranted to determine the therapeutic role of spironolactone in CAPD patients with concomitant congestive heart failure or cardiovascular disease.

Related Articles

Peritoneal Protein Losses in Diabetic Patients Starting Peritoneal Dialysis: Is There a Relationship with Diabetic Vascular Lesions
Advances in Peritoneal Dialysis, 10/21/09    Relevance Score: 97%

Successful treatment of calcific uremic arteriolopathy in a pediatric dialysis patient
Pediatric Nephrology, 11/11/09    Relevance Score: 96%

Systemic and Intraperitoneal Proinflammatory Cytokine Profiles in Patients on Continuous Ambulatory Peritoneal Dialysis
Advances in Peritoneal Dialysis, 10/20/09    Relevance Score: 96%

Use of Peritoneal Dialysis and Mesothelium in Non Primary Renal Conditions
Advances in Peritoneal Dialysis, 10/16/09    Relevance Score: 96%

Pharmacokinetics of moxifloxacin in patients undergoing continuous ambulatory peritoneal dialysis
Peritoneal Dialysis International, 10/01/09    Relevance Score: 96%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address